Completed OBSERVATIONAL NCT01976689

New-onset Diabetes and Left Ventricular Hypertrophy in Renal Transplantation

New- Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients

Sponsor: Baskent University

Conditions Diabetes Mellitus Nos New Onset Hypertrophy, Left Ventricular Vascular Stiffness

Updated 7 times since 2017 Last updated: Nov 6, 2013 Started: Mar 31, 2012 Primary completion: Mar 31, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Diabetes Mellitus Nos New Onset and Hypertrophy, Left Ventricular, this trial is completed. The trial is conducted by Baskent University and has accumulated 7 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Mar 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baskent University

Data source: Baskent University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)